Equillium, Inc.

16
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29446K1060
USD
0.87
0.01 (1.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Equillium, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-7.00
-12.00
-62.00
-39.00
-29.00
-25.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
-2.00
0.00
1.00
1.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-19.00
-21.00
-8.00
-32.00
-24.00
-22.00
Cash Flow from Investing Activities
13.00
-4.00
18.00
27.00
-18.00
-2.00
Cash Flow from Financing Activities
0.00
-9.00
-1.00
31.00
53.00
9.00
Net Cash Inflow / Outflow
-5.00
-35.00
8.00
26.00
10.00
-15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Equillium, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-7.706
-60.663
53.00
87.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.842
-1.321
1.00
163.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-19.026
-20.713
1.00
8.14%
Cash Flow from Investing Activities
13.814
-0.512
13.00
2798.05%
Cash Flow from Financing Activities
0.164
20.429
-20.00
-99.20%
Net Cash Inflow / Outflow
-5.131
-0.796
-5.00
-544.60%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.083
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 12.66% vs -149.43% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-19.03
-21.78
12.66%